Uramustine
From Wikipedia, the free encyclopedia
(Redirected from Uracil mustard)
 |
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009) |
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 5-[bis(2-chloroethyl)amino]-1H-pyrimidine-2,4-dione | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Pharmacokinetic data | |
| Protein binding | 5% |
| Excretion | Renal |
| Identifiers | |
| CAS number | 66-75-1  |
| ATC code | None |
| PubChem | CID 6194 |
| DrugBank | APRD00130 |
| UNII | W7KQ46GJ8U  |
| KEGG | D06265 |
| ChEMBL | CHEMBL1488 |
| Chemical data | |
| Formula | C8H11Cl2N3O2 |
| Mol. mass | 252.097 g/mol |
 (what is this?) (verify) |
|
Uramustine (INN) or uracil mustard is a chemotherapy drug which belongs to the class of alkylating agents. It is used in lymphatic malignancies such as non-Hodgkin's lymphoma. It works by damaging DNA, primarily in cancer cells that preferentially take up the uracil due to their need to make nucleic acids during their rapid cycles of cell division. The DNA damage leads to apoptosis of the affected cells. Bone marrow suppression and nausea are the main side effects.
Chemically it is a derivative of nitrogen mustard and uracil.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
